Cook Medical announced that the Zenith Alpha 2 (ZTA2) thoracic endovascular graft is commercially available in the United ...
A team of researchers at Cornell University has developed a new biodegradable vascular graft that could transform the treatment of cardiovascular disease, the leading cause of death worldwide.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback